FDL169
FDL-169 is a novel and potent CFTR (Cystic fibrosis transmembrane conductance regulator) corrector for treating cystic fibrosis (CF) patients who carry the F508del mutation.
Product Specifications
CAS Number
1628416-28-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
486.49
Molecular Formula
C27H23FN4O4
Notes
Research use only, not for human use.
Receptor
CFTR
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1321590-01 0.02 mg (E-Coli)
Recombinant Lactobacillus johnsonii Serine--tRNA ligase (serS)
Ask
View Details MBS1321590-02 0.02 mg (Yeast)
Recombinant Lactobacillus johnsonii Serine--tRNA ligase (serS)
Ask
View Details 
MBS1321590-03 0.1 mg (E-Coli)
Recombinant Lactobacillus johnsonii Serine--tRNA ligase (serS)
Ask
View Details MBS1321590-04 0.1 mg (Yeast)
Recombinant Lactobacillus johnsonii Serine--tRNA ligase (serS)
Ask
View Details MBS1321590-05 0.02 mg (Baculovirus)
Recombinant Lactobacillus johnsonii Serine--tRNA ligase (serS)
Ask
View Details MBS1321590-06 0.02 mg (Mammalian-Cell)
Recombinant Lactobacillus johnsonii Serine--tRNA ligase (serS)
Ask
View Details